Biotechnology News

April 11, 2014

MADISON, Wis.--(BUSINESS WIRE)--In partnership with the (WEDC) and University Research Park, BioForward is awarding 25 attendees from Wisconsin companies scholarships to participate in the BIO International Convention.

April 11, 2014

WASHINGTON--(BUSINESS WIRE)--Ian C. Read, chairman and CEO of Pfizer, Inc, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association’s annual meeting. Also elected were Kenneth C....

April 11, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GnuBIO announced that it was acquired by Bio-Rad Laboratories, Inc.

April 11, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc today announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline™ Embolization Device and Alligator™ Retrieval Device where the...

April 11, 2014

SEATTLE--(BUSINESS WIRE)--April 11, 2014 – Dendreon Corporation (NASDAQ:DNDN) today announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses appear to...

April 11, 2014

LYON, France--(BUSINESS WIRE)--The MEDICREA group (Paris:ALMED) (FR0004178572-ALMED), listed on Alternext Paris and eligible for PEA-PME SME equity savings plans, a company that specializes in the development of innovative surgical technologies...

April 11, 2014

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics collaborator Todd Bauer, MD presented at AACR on using combination therapy of the MEK inhibitor trametinib plus mibefradil to treat pancreatic cancer and overcome acquired resistance.

April 11, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The summary is a shorter document that summarises the main points in the Annual Report 2013, but is not a substitute for it and does not contain all the information needed to give as full an...

April 11, 2014

PARIS--(BUSINESS WIRE)--The Fondation Ipsen is celebrating its 30th anniversary. During these three decades, it has gone hand in hand with the evolution of biomedical research at the highest level, organizing the first scientific conferences on...

April 11, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that detailed...

April 11, 2014

LONDON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from two Phase 2 studies and a compassionate access study in which a regimen containing once-daily Sovaldi® (sofosbuvir) 400 mg was administered for the treatment...

April 11, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced interim results from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of a regimen combining MK-5172 and MK-8742.

April 10, 2014

BOSTON--(BUSINESS WIRE)--Vertex to announce its first quarter 2014 financial results on Thursday, May 1, 2014 after the financial markets close.

April 10, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Results from the 2014 British Association for Surgery of the Knee (BASK) meeting highlight excellent patient satisfaction, normal feel and neutral alignment critical to long-term survivorship

April 10, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Precision Biologics presents further encouraging results from NEO-102 in pancreatic and colorectal cancer patients.

April 10, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--TOPCAT clinical trial finds spironolactone significantly reduces the risk of heart failure hospitalizations but nixes its effect on cardiovascular death or sudden cardiac arrest

April 10, 2014

WASHINGTON--(BUSINESS WIRE)--Today the Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that outlines two potential growth trajectories for the U.S. biopharmaceutical sector and the top policy factors that enable the...

April 10, 2014

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS has appointed Dianne Blanco, CEO of Orteq, as one of the company's directors. She has more than 20 years experience in key management positions throughout the medical technology industry.

April 10, 2014

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc.

April 10, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--The 10th Annual PRO & eCOA Congress hosted by PHT Corporation reaffirmed the need for electronic clinical outcome assessment (COA) Systems recommended by FDA PRO Guidance to improve clinical research

April 10, 2014

WASHINGTON--(BUSINESS WIRE)--BIO and Delaware Bio commend the Delaware State Senate for passing legislation yesterday designed to create a pathway for the substitution of interchangeable biologic medicines.

April 10, 2014

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Leading CRO Chooses Instem Software Solutions for Global Multi-Site Deployment

April 10, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--The Premier Israel Hi-tech And Biomed Conference Is Set To Take Place In Tel Aviv On May 20th - 22nd; Organization Shares That Registration Is Set To Close On April 30th

April 10, 2014

HAIFA, Israel--(BUSINESS WIRE)--Bonus BioGroup announces it has commenced a clinical trial for the repair of human facial bone deficiency, including upper or lower jawbone cavitation by transplantation of live human bone grafts

April 10, 2014

WASHINGTON--(BUSINESS WIRE)--DIA 2014 50th Annual Meeting to Highlight New IMI Collaborative Initiative; GetReal project seeks practical solutions for integrating real-world data to better inform the drug development process

April 10, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems presents new data at Thrombosis and Hemostasis Summit of North America demonstrating ability of T2MR platform technology to measure platelet activity & other hemostasis parameters

April 10, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Respiratory experts will present a live, interactive webinar at 10 a.m. EDT on Wednesday, April 23.

April 10, 2014

LAS VEGAS--(BUSINESS WIRE)--Medican Enterprises Inc. (OTCBB: MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce its wholly owned subsidiary Canaleaf Systems Inc. (the Company) has signed a...

April 10, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec names Adam Koppel as SVP and Chief Strategy Officer.

April 10, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea announces presentation at AACR by UCSF researchers on the potential utility of Manocept platform imaging agents in identifying affected tissues and lymph nodes in patients with Kaposi Sarcoma.

April 10, 2014

GOETTINGEN, Germany--(BUSINESS WIRE)--At today’s Annual Shareholders’ Meeting in Goettingen, Germany, shareholders approved the board proposals by a large majority. Thus, the Annual Shareholders' Meeting passed the resolution to pay dividends of...

April 10, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences Integrates SimulConsult’s Genome-Phenome Analyzer to Enhance the Clinical Genetic Analysis for Neurological and Metabolic Disorders

April 10, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced Phase III results from the global HALLMARK-Dual study investigating the all-oral, interferon- and ribavirin-free regimen of daclatasvir (DCV), a NS5A...

April 10, 2014

CAMBRIDGE, Mass. & STOCKHOLM--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) and Swedish Orphan Biovitrum AB (publ) (Sobi) (STO: SOBI) today released positive top-line results of the Kids A-LONG Phase 3 clinical study that evaluated the safety...

April 10, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that the Company will host a Research and Development Day on Friday, May 2, from 8:30...

April 10, 2014

JERUSALEM--(BUSINESS WIRE)--BioLineRx Announces Investigator-Initiated Study for Novel Chronic Myeloid Leukemia Treatment- Phase 1/2 study will assess effect of BL-8040 in combination with standard therapy

April 10, 2014

NANJING, China--(BUSINESS WIRE)--experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing.

April 10, 2014

GENEVA & ARCHAMPS, France--(BUSINESS WIRE)--Genkyotex’s GKT137831 Reverses Fibrosis and Improve Survival in a Model of Persistent Lung Fibrosis. Data published in Science Translational Medicine

April 10, 2014

LONDON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from two Phase 2 studies evaluating investigational all-oral regimens containing the nucleotide analog polymerase inhibitor sofosbuvir (SOF) for the treatment of...

April 10, 2014

LONDON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from an open-label clinical trial (Study GS-US-334-0109) evaluating once-daily Sovaldi® (sofosbuvir) 400 mg tablets for the retreatment of chronic hepatitis C...

April 10, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced additional data from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of a once-daily, all-oral regimen.

April 9, 2014

WASHINGTON--(BUSINESS WIRE)--BIO announced today its selection of Senator Roy Blunt (R-MO) as a Legislator of the Year. Senator Blunt receives the award in conjunction with today’s BIO Legislative Day Fly-In.

April 9, 2014

WASHINGTON--(BUSINESS WIRE)--BIO announced its selection of Congressman Rush Holt (D-NJ) as a Legislator of the Year for 2013-2014. Representative Holt received the award in conjunction with today’s BIO Legislative Day Fly-In.

April 9, 2014

NEW YORK--(BUSINESS WIRE)--Deerfield Management Company announced today that it has entered into a financing agreement with OMNIlife science, Inc. to invest $27.5mm. The purpose of the funding is to strengthen the Company’s balance sheet, to...

April 9, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. announced that it has completed its previously announced underwritten public offering of its common stock at a price of $12.75 per share to the public.